G. Tan

CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy.

A. Wu, S. Forman, M. Jensen, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human T lymphocyte genetic modification with naked DNA.

M. Slovak, A. Wu, S. Forman, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.

Jinha M. Park, A. Wu, M. Press, 2004, Protein engineering, design & selection : PEDS.

Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.

A A Raubitschek, A. Wu, M. Sherman, 2001, Protein engineering.